124 related articles for article (PubMed ID: 9667648)
21. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor expression in colorectal cancer.
Steele RJ; Kelly P; Ellul B; Eremin O
Br J Surg; 1990 Dec; 77(12):1352-4. PubMed ID: 2276016
[TBL] [Abstract][Full Text] [Related]
24. Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor-hyperproducing human tumor cells.
Hirai M; Gamou S; Minoshima S; Shimizu N
J Cell Biol; 1988 Aug; 107(2):791-9. PubMed ID: 2458359
[TBL] [Abstract][Full Text] [Related]
25. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
Mórocz IA; Schmitter D; Lauber B; Stahel RA
Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
27. FGF18 in colorectal tumour cells: autocrine and paracrine effects.
Sonvilla G; Allerstorfer S; Stättner S; Karner J; Klimpfinger M; Fischer H; Grasl-Kraupp B; Holzmann K; Berger W; Wrba F; Marian B; Grusch M
Carcinogenesis; 2008 Jan; 29(1):15-24. PubMed ID: 17890768
[TBL] [Abstract][Full Text] [Related]
28. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract.
Playford RJ; Hanby AM; Gschmeissner S; Peiffer LP; Wright NA; McGarrity T
Gut; 1996 Aug; 39(2):262-6. PubMed ID: 8977341
[TBL] [Abstract][Full Text] [Related]
29. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
Rachwal WJ; Bongiorno PF; Orringer MB; Whyte RI; Ethier SP; Beer DG
Br J Cancer; 1995 Jul; 72(1):56-64. PubMed ID: 7599067
[TBL] [Abstract][Full Text] [Related]
30. Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.
Blanchot-Jossic F; Jarry A; Masson D; Bach-Ngohou K; Paineau J; Denis MG; Laboisse CL; Mosnier JF
J Pathol; 2005 Oct; 207(2):156-63. PubMed ID: 16041691
[TBL] [Abstract][Full Text] [Related]
31. Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
Veluchamy JP; Spanholtz J; Tordoir M; Thijssen VL; Heideman DA; Verheul HM; de Gruijl TD; van der Vliet HJ
PLoS One; 2016; 11(6):e0157830. PubMed ID: 27314237
[TBL] [Abstract][Full Text] [Related]
32. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
Shirai H; Ueno E; Osaki M; Tatebe S; Ito H; Kaibara N
Anticancer Res; 1995; 15(6B):2889-94. PubMed ID: 8669884
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.
Liu C; Park M; Tsao MS
Oncogene; 1992 Jan; 7(1):181-5. PubMed ID: 1741162
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Caco-2 cell proliferation by basolateral membrane epidermal growth factor receptors.
Bishop WP; Wen JT
Am J Physiol; 1994 Nov; 267(5 Pt 1):G892-900. PubMed ID: 7977752
[TBL] [Abstract][Full Text] [Related]
36. Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell line.
Hamburger AW; Pinnamaneni GD
Br J Cancer; 1991 Jul; 64(1):64-8. PubMed ID: 1906727
[TBL] [Abstract][Full Text] [Related]
37. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
Filipe MI; Osborn M; Linehan J; Sanidas E; Brito MJ; Jankowski J
Br J Cancer; 1995 Jan; 71(1):30-6. PubMed ID: 7819044
[TBL] [Abstract][Full Text] [Related]
38. Heparin-binding epidermal growth factor-like growth factor and transforming growth factor-alpha in human non-small cell lung cancers.
Chong IW; Lin SR; Lin MS; Huang MS; Tsai MS; Hwang JJ
J Formos Med Assoc; 1997 Aug; 96(8):579-85. PubMed ID: 9290266
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
40. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
